| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. | General Counsel | Voting Common Stock | 191,582 | $3,653,468 | $19.07 | 05 Feb 2026 | Direct |
| MapLight Therapeutics, Inc. | General Counsel | Employee Stock Option (right to buy) | 31,395 | 05 Feb 2026 | Direct | ||
| PhaseBio Pharmaceuticals Inc | SVP and General Counsel | Common Stock | 8,463 | 20 May 2022 | Direct |